Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Inst...
CUMBERLAND, Rhode Island, and LA JOLLA, California, Jan. 17, 2019 /PRNewswire-AsiaNet/ -- The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been published in the journal of the American Academy of Ophthalmology, Ophthal...
Read more https://view-release/?pr-id=77093